-transparent.png){kind=logo}
The clinical and social effects of flupenthixol decanoate and fluphenazine decanoate were compared in the maintenance treatment of a population of chronic schizophrenic out-patients over a period of 9 months. The results failed to show significant difference between the treatments, and in particular, reports suggesting specific advantages for flupenthixol decanoate in alleviating the negative symptoms of apathy, anergia and depression in chronic schizophrenics were not confirmed. It seems that chronic schizophrenic patients who are well established on one depot preparation are unlikely to be benefited by being changed to the alternative.
Related Publications
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
December 1985,
Singapore medical journal,
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
January 1989,
Pharmatherapeutica,
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
May 1975,
Acta psychiatrica Scandinavica,
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
October 1979,
Acta psychiatrica Scandinavica,
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
January 1987,
Progress in neuro-psychopharmacology & biological psychiatry,
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
February 1975,
Acta psychiatrica Scandinavica,
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
October 1986,
Ceskoslovenska psychiatrie,
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
December 1980,
The British journal of psychiatry : the journal of mental science,
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
May 1976,
The New Zealand medical journal,
H B Kelly, and
H L Freeman, and
B Banning, and
A A Schiff
December 1981,
Activitas nervosa superior,
